Delivery Order SPE2DR25D2014-SPE2DR26FA4D0
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for Lantus SoloStar 100 Unit/mL insulin pens with a ceiling value of $1,022.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order by the Defense Logistics Agency on January 27, 2026, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $1,286.98. This is a non-set-aside competitive award with an ultimate completion date of January 28, 2026, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order issued under...
- AmerisourceBergen Drug Corp has been awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ML insulin pens, valued at $1,294.28. The order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery requirement from its corporate office location....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $3,414.70. This firm fixed price delivery order, with an ultimate completion date of June 18, 2025, represents a single-unit transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award...
- AmerisourceBergen Drug Corp was awarded a $1,197.07 firm fixed-price delivery order by the Defense Logistics Agency on July 18, 2025, for Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,051.98 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $4,398.30. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,994.33 delivery order for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a completion date of December 23, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,770.53 for Lantus SoloStar 100 Unit/mL 3mL insulin pens on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 12, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations facility. This delivery order is issued under...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $5,439.09 to supply Lantus SoloStar 100 unit/ml pre-filled insulin pens. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 3, 2023. This order was awarded against an existing contract vehicle and did not contain a set-aside designation. As a leading pharmaceutical distributor,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA4D0Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,431.23 by the Defense Logistics Agency on January 29, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 30, 2026. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary indefinite delivery contract with the Defense Logistics Agency. The delivery order fulfills critical pharmaceutical needs for military healthcare systems and reflects the company's established role as a preferred vendor for federal medical procurement. The performance of work will occur at the contractor's Conshohocken, Pennsylvania facility, with delivery expected within one day of the award date.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/28/26 |